These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3319499)

  • 1. Cephalosporins in urinary tract infection.
    Gentry LO
    Drugs; 1987; 34 Suppl 2():154-63. PubMed ID: 3319499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR
    Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
    Perry CM; Brogden RN
    Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections.
    Iravani A; Richard GA
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1212-6. PubMed ID: 2802549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.
    Wiseman LR; Benfield P
    Drugs; 1993 Feb; 45(2):295-317. PubMed ID: 7681376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
    Scott LJ; Ormrod D; Goa KL
    Drugs; 2001; 61(10):1455-500. PubMed ID: 11558834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil.
    Leigh DA; Joy GE; Tait S; Harris K; Walsh B
    J Antimicrob Chemother; 1989 Feb; 23(2):267-73. PubMed ID: 2708184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and safety of cefprozil and cefaclor in the treatment of acute uncomplicated urinary tract infections.
    Christenson JC; Gooch WM; Herrod JN; Swenson E
    J Antimicrob Chemother; 1991 Oct; 28(4):581-6. PubMed ID: 1761453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections.
    Bonsu BK; Shuler L; Sawicki L; Dorst P; Cohen DM
    Acad Emerg Med; 2006 Jan; 13(1):76-81. PubMed ID: 16365328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin.
    Williams KJ; Hebblethwaite EM; Brown GW; Cox DM; Plested SJ
    Drugs Exp Clin Res; 1987; 13(2):95-9. PubMed ID: 3556123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in-vitro activity of cefaclor against urinary tract isolates of Escherichia coli.
    Webster CA; Curran R; Towner KJ
    J Antimicrob Chemother; 1996 Jul; 38(1):59-66. PubMed ID: 8858457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection.
    Adams DH; Wood MJ; Farrell ID; Fox C; Ball AP
    J Antimicrob Chemother; 1985 Sep; 16(3):359-66. PubMed ID: 4055543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A newer cephalosporin (cephradine) in the treatment of urinary tract infections.
    Gulati PD; Agarwal DS; Baweja U; Sethi K; Geeta V
    J Assoc Physicians India; 1977 Apr; 25(4):249-54. PubMed ID: 334716
    [No Abstract]   [Full Text] [Related]  

  • 15. [Double-blind comparative clinical study of cefpiramide (SM-1652) and cefsulodin on complicated urinary tract infections due to P. aeruginosa].
    Kawamura N; Ohkoshi M; Okada K; Kumamoto Y; Miyamoto S; Niijima T; Kishi Y; Nishimura Y; Saito I; Yuge J
    Hinyokika Kiyo; 1983 Sep; 29(9):1147-88. PubMed ID: 6375316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of urinary nitrites is a significant predictor of pediatric urinary tract infection susceptibility to first- and third-generation cephalosporins.
    Weisz D; Seabrook JA; Lim RK
    J Emerg Med; 2010 Jul; 39(1):6-12. PubMed ID: 18757159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetic Analysis of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Healthy Subjects, Subjects with Various Degrees of Renal Function, and Patients with Complicated Urinary Tract Infection or Acute Uncomplicated Pyelonephritis.
    Kawaguchi N; Katsube T; Echols R; Wajima T
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29038272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftriaxone, a new parenteral cephalosporin, in the treatment of urinary tract infections.
    Bernstein Hahn L; Barclay CA; Iribarren MA; Traballi CA
    Chemotherapy; 1981; 27 Suppl 1():75-9. PubMed ID: 7018853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical comparison of cefadroxil, new oral cephalosporin, and cephalexin in uncomplicated urinary tract infection.
    Bolding OT
    Urology; 1978 Sep; 12(3):321-4. PubMed ID: 360561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral cephalosporins in perspective.
    Smith GH
    DICP; 1990 Jan; 24(1):45-51. PubMed ID: 2405586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.